
Diabetes Medication (from ADA 2020)
Authored by Chrismar Mocorro
Other, Specialty
Professional Development
Used 7+ times

AI Actions
Add similar questions
Adjust reading levels
Convert to real-world scenario
Translate activity
More...
Content View
Student View
10 questions
Show all answers
1.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Medication with high efficacy in decrease HBAIC are the following except?
Sitagliptin
Liraglutide
Pioglitazone
no exceptions
Answer explanation
SGLT2 inhibitors (empagliflozin, etc) and DPP-4 inhibitors ( Sitagliptin, etc) have only intermediate efficacy. Metformin, GLP-1 RAs (liraglutide), Thiazolidendiones (pioglitazone) and Sulfonylureas (gliclazide, glimeperidie) have high efficacy. Insulin has the highest efficacy
2.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
What medications have high risks for hypoglycemia?
Sitagliptin
Pioglitazone
Liraglutide
all of the above
none of the above
Answer explanation
Only Sulfonylureas (2nd generation) and Insulin have high for developing hypoglycemia. The risk have no risk for developing hypoglycemia.
3.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
What medication cause weight loss?
Sitagliptin
liraglutide
empagliflozin
all of the above
sitagliptin and empagliflozin
Answer explanation
weight loss - meftormin, sglt2 inhibitors, glp 1 RAs
neutral - DPP4 inhibitors
weight gain - thiazolidendiones, sulfonylureas, insulin
pneumonics for weight loss --
mag floz ka, ma loss imo ki-ki, empagliFLOZin, canagliFLOZin, dapagliFLOZin)
maglaba ka gamit TIDE, makaniwang jud na (liragluTIDE, lixisenaTIDE)
4.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Which medication has a benefit or potential benefit for decreasing risk for ASCVD?
empagliflozin
metformin
liraglutide
pioglitazone
all of the above
Answer explanation
potential benefit: metformin and pioglitazone
benefit: empagliflozin, canagliflozin, GLP-1 RAs (meds ending with TIDE) except lixisenatide
ADA recommendations:
Among patients with type 2 diabetes who have established Atheroscleortic cardiovascular disease or indications of high risk established kidney disease, or heart failure, a SGLT-2 inhibitor or GLP 1 RA with demonstrated CVD benefit is recommended.
5.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
What medication is contraindicated for heart failure?
dapagliflozin
pioglitazone
liraglutide
all of the above
none of the above
Answer explanation
pioglitaZONE- has increased risk for heart failure (tungod sa water retention, mao ng maka weight gain sad sya)
SAXAgliptin - potential risk for HF
empagliflozin, canagliflozin, and dapagliflozin - benefit for HF
pnemonics:
kung ma-friendZONE ka, makaheartbroken jud, ma heart failure ka, maSAXAktan ka talga
6.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
Which DPP4 inhibitors does not need renal dose adjustment?
linagliptin
sitagliptin
saxagliptin
all needs renal dose adjustment
all does not need renal dose adjustment
Answer explanation
pneumonics:
LINAgliptin - maLINAw na hindi kailangan ng Renal dose adjustment. mas maLINAw pa sa kulay ni LIto Lapid at NAncy binay.
7.
MULTIPLE CHOICE QUESTION
30 sec • 1 pt
What medication has a risk for amputation ?
canagliflozin
liraglutide
sitagliptin
pioglitzone
Answer explanation
CANEagliflozin - na amputate mao ng CANE na sya
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports

Continue with Google

Continue with Email

Continue with Classlink

Continue with Clever
or continue with

Microsoft
%20(1).png)
Apple
Others
Already have an account?